See also this year's filing and all EDGAR filings for this company.
PDF Report 0001156039_2022_Elevance_Health_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 99.60885341074021, 'aggregate_val': 138639000000, 'exp_sum': 1378000000, 'exp_to_value': {'PremiumsEarned': 0, 'InvestmentIncome': 1378000000, 'InsuranceCommissionsAndFees': 0, 'remainder_Revenues': 0}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 104.45117845117845, 'aggregate_val': 156595000000, 'exp_sum': 1485000000, 'exp_to_value': {'PremiumsEarned': 0, 'InvestmentIncome': 1485000000, 'InsuranceCommissionsAndFees': 0, 'remainder_Revenues': 0}} |
Graph
Absolute values for 0001156039, Elevance Health Inc
| xvar | xval | |
|---|---|---|
| 0 | Investments | 0 |
| 1 | SeparateAccountAssets | 0 |
| 2 | PremiumsReceivable | 5,681,000,000 |
| 3 | DeferredPolicyAcquisitionCosts | 0 |
| 4 | ReinsuranceRecoverables | 0 |
| 5 | IntangibleAssets | 34,843,000,000 |
| 6 | AssetsCurrent | 51,122,000,000 |
| 7 | AssetsNonCurrent | 3,919,000,000 |
| 8 | remainder_Assets | 1,895,000,000 |
| 9 | LiabilityForClaimsAndClaimsAdjustmentExpense | 14,320,000,000 |
| 10 | PolicyholderContractDeposits | 5,521,000,000 |
| 11 | LiabilitiesCurrent | 34,885,000,000 |
| 12 | UnearnedPremiums | 1,153,000,000 |
| 13 | ReinsurancePayable | 0 |
| 14 | LongTermDebt | 22,840,000,000 |
| 15 | remainder_Liabilities | -17,387,000,000 |
| 16 | PolicyholderBenefitsAndClaims | 103,498,688,428 |
| 17 | SellingGeneralAndAdministrativeExpense | 26,843,143,361 |
| 18 | DeferredPolicyAcquisitionCostAmortizationExpense | 0 |
| 19 | remainder_Expenses | 3,040,575,456 |
| 20 | PremiumsEarned | 0 |
| 21 | InvestmentIncome | 1,408,649,279 |
| 22 | InsuranceCommissionsAndFees | 0 |
| 23 | remainder_Revenues | 141,407,712,351 |
| 24 | Revenues_Y1 | 141,973,334,273 |
| 25 | Revenues_Y2 | 142,646,501,521 |
| 26 | Revenues_Y3 | 142,783,013,108 |
| 27 | Revenues_Y4 | 142,810,731,456 |
| 28 | Revenues_Y5 | 142,816,361,630 |
| 29 | remainder_NetIncome | 0 |
| 30 | remainder_ComprehensiveNetIncome | -114,803,068 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 97,460,000,000 |
| 1 | Liabilities | 61,332,000,000 |
| 2 | Expenses | 133,382,407,246 |
| 3 | Revenues | 142,816,361,630 |
| 4 | StockholdersEquity | 36,128,000,000 |
| 5 | NetIncome | 9,433,954,385 |
| 6 | ComprehensiveNetIncome | 9,376,552,850 |
| 7 | BaseVar | 9,477,816,814,416 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.700 |
| 9 | EconomicCapitalRatio | 1.36 |
Edgar->Model Mapping
Feature Distribution
Company Valuation
Change over Time
